Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade - Concepedia

Concepedia

Publication | Closed Access

Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade

27

Citations

42

References

2024

Year

Habib Hamidi, Yasin Şenbabaoğlu, Niha Beig, Juliette Roels, C Manuel, Xiangnan Guan, Hartmut Koeppen, Zoe J. Assaf, Barzin Y. Nabet, A W Waddell,

Molecular HeterogeneityUrologyGenitourinary CancerPd-l1 BlockadeUrothelial CarcinomaMedicineImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyTumor Microenvironment

References

	Year	Citations

Page 1

Page 1